Stock A137310 SD BIOSENSOR, INC
Add to a list
To use this feature you must be a member
Log inSign up

Financials SD BioSensor, Inc

Equities

A137310

KR7137310009

Medical Equipment, Supplies & Distribution

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-06-06 pm EDT 		5-day change 1st Jan Change
9,960 KRW +0.40% Intraday chart for SD BioSensor, Inc -0.80% -12.94%
2023 SD Biosensor, Inc announced that it has received KRW 226.0893359 billion in funding from BioNote, Inc. CI
2023 SD Biosensor, Inc announced that it expects to receive KRW 226.0893359 billion in funding from BioNote, Inc. CI

Valuation

Fiscal Period: December 2021 2022 2023 2024
Capitalization 1 5,736,545 3,074,925 1,399,655 1,218,581
Enterprise Value (EV) 1 5,735,340 3,073,005 1,399,511 1,218,581
P/E ratio 5.16 x 3.46 x -2.71 x -
Yield 2.26% 6.49% 2.53% -
Capitalization / Revenue 1.96 x 1.05 x 2.13 x 1.72 x
EV / Revenue 1.96 x 1.05 x 2.13 x 1.72 x
EV / EBITDA 4,130,191,783 x 2,589,532,084 x -12,661,591,653 x -
EV / FCF 5,490,084 x 5,227,385 x -3,636,559 x -
FCF Yield 0% 0% -0% -
Price to Book 2.58 x 1.07 x 0.45 x -
Nbr of stocks (in thousands) 102,622 101,988 122,347 122,347
Reference price 2 55,900 30,150 11,440 9,960
Announcement Date 2/25/22 3/9/23 2/28/24 -
1KRW in Million2KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023 2024
Net sales 1 - 2,931 2,928 655.7 707.3
EBITDA - 1,389 1,187 -110.5 -
EBIT 1 - 1,370 1,147 -248.1 -46.8
Operating Margin - 46.73% 39.16% -37.83% -6.62%
Earnings before Tax (EBT) - 1,444 1,242 -438.6 -
Net income 1 615.6 1,066 883.4 -467.7 -64.3
Net margin - 36.36% 30.17% -71.33% -9.09%
EPS 6,583 10,824 8,721 -4,219 -
Free Cash Flow - 1,044,892 588,234 -384,884 -
FCF margin - 35,644.57% 20,087.21% -58,700.35% -
FCF Conversion (EBITDA) - 75,230.03% 49,537.81% - -
FCF Conversion (Net income) - 98,027.29% 66,585.09% - -
Dividend per Share - 1,266 1,957 290.0 -
Announcement Date 5/14/21 2/25/22 3/9/23 2/28/24 -
1KRW in Billions
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4
Net sales 1 443.8 1,388 795 551.2 193.8 182.4 162.6 151 159.6
EBITDA 1 - - - - - - - -9.591 13.3
EBIT 1 147.9 619.6 348.1 293.4 -114.6 -123.8 -76.41 -44.24 -29.61
Operating Margin 33.32% 44.63% 43.79% 53.24% -59.13% -67.86% -46.98% -29.29% -18.55%
Earnings before Tax (EBT) 156 648.7 466.9 487.4 -361 - - - -
Net income 1 130.5 474.5 340 421.3 -352.4 - -82.49 -64.12 -98.43
Net margin 29.4% 34.17% 42.77% 76.44% -181.84% - -50.72% -42.45% -61.67%
EPS - - - - - - - - -
Dividend per Share - - - - - - - - -
Announcement Date 2/25/22 5/12/22 8/3/22 11/3/22 3/9/23 5/15/23 8/11/23 11/13/23 2/28/24
1KRW in Billions
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023 2024
Net Debt - - - - -
Net Cash position - 1,205 1,921 144 -
Leverage (Debt/EBITDA) - - - - -
Free Cash Flow - 1,044,892 588,234 -384,884 -
ROE (net income / shareholders' equity) - 72% 34.2% -15.6% -
ROA (Net income/ Total Assets) - 47.7% 29% -13.3% -
Assets 1 - 2,236 3,051 3,525 -
Book Value Per Share - 21,658 28,207 25,471 -
Cash Flow per Share - 12,554 8,788 - -
Capex - 190 302 143 -
Capex / Sales - 6.48% 10.31% 21.74% -
Announcement Date 5/14/21 2/25/22 3/9/23 2/28/24 -
1KRW in Billions
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
9,960
Average target price
-
Consensus

Quarterly revenue - Rate of surprise

Company calendar

Sector Diagnostic & Testing Substances

1st Jan change Capi.
SD BIOSENSOR, INC Stock SD BioSensor, Inc
-12.94% 884M
BIOMÉRIEUX Stock bioMérieux
-6.76% 11.98B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD. Stock Shenzhen New Industries Biomedical Engineering Co., Ltd.
-5.68% 8B
DIASORIN S.P.A. Stock DiaSorin S.p.A.
+8.91% 5.85B
LANTHEUS HOLDINGS, INC. Stock Lantheus Holdings, Inc.
+28.87% 5.54B
AUTOBIO DIAGNOSTICS CO., LTD. Stock Autobio Diagnostics Co., Ltd.
-15.84% 3.84B
ANDON HEALTH CO., LTD. Stock Andon Health Co., Ltd.
+10.70% 2.66B
10X GENOMICS, INC. Stock 10x Genomics, Inc.
-60.92% 2.62B
VITROLIFE AB Stock Vitrolife AB
-6.99% 2.33B
MYRIAD GENETICS, INC. Stock Myriad Genetics, Inc.
+15.67% 2B
Diagnostic & Testing Substances
  1. Stock Market
  2. Equities
  3. A137310 Stock
  4. Financials SD BioSensor, Inc